A B S T R A C T Patients with porphyrias have varying degrees of photosensitivity, associated with elevated levels of porphyrins in plasma, erythrocyte, urine and/ or feces. To investigate the role of complement in the pathogenesis of cutaneous lesions, varying amounts of uroporphyrin were added to normal human serum (0.1-10 ZgIml), and the mixtures were then exposed to 405 nm irradiation. Such treatments result in the diminution of total hemolytic complement activity and hemolytic titers of Cl, C4, C2, C3, and C5; furthermore, cleavage products of C3 and C5 were detected. Chemotactic activity for human polymorphonuclear leukocytes was generated that was inhibitable by incubation with anti-C5, but not with anti-C3 antisera. No chemotactic activity was generated in Mg++-EGTA treated serum nor in C4-deficient guinea pig serum. These data indicate that irradiation with 405 nm light of normal human serum containing uroporphyrin results in activation of the complement system via the classical pathway, and the generation of complement (C5)-derived chemotactic activity for human polymorphonuclear leukocytes.
INTRODUCTION
Porphyrias are a group ofmetabolic diseases characterized by elevated levels of porphyrins in plasma, erythrocytes, urine, and/or feces. Upon Received for publication 18 August 1980 and in revisedform 17 November 1980. 1072 of the skin, with subsequent formation of blisters. Scarring occurs after repeated attacks (1) .
Exposure of patients with erythropoietic protoporphyria to light containing the action spectrum of porphyrin molecules (405 nm) results in lysis of capillary endothelial cells, mast cell degranulation, and the appearance of polymorphonuclear leukocytes (PMN)1 in the dermis (2) . Direct immunofluorescence studies of exposed skin from patients with porphyrias demonstrated deposition of C3 and immunoglobulins around blood vessels and at the dermo-epidermal junction (3, 4) . These observations, together with our finding of decreased levels ofcomplement in serum from patients with erythropoietic protoporphyria after irradiation in vitro (5) , prompted us to consider the possibility that products of complement activation may play a role in the pathogenesis of cutaneous lesions in the porphyrias. Recently, using an animal model, we have obtained evidence in support of this possibility. We were able to demonstrate that in guinea pigs injected intraperitoneally with porphyrins, irradiation with 405 nm light produced cutaneous lesions as well as marked diminution of total serum hemolytic complement activity (6) .
We now present data indicating that irradiation with 405 nm light of normal human serum containing uroporphyrin results in activation of the complement system via the classical pathway and generation of complement (C5)-derived chemotactic activity for human PMN.
METHODS
Source of serum. Pooled sera from healthy adult volunteers were processed and used as previously described (5 [GVB++] , GVB containing dextrose [DGVB++], EA, EAC1, and EAC14) were prepared as previously described (7) . These were used to measure hemolytic titers of total complement activity, Cl, C4, C2, C3, and C5 (6, 7) .
Crossed immunoelectrophoresis. Two-dimensional (crossed) immunoelectrophoresis was performed employing minor modifications of the method of Laurell (8) . Goat antisera to human C3 and human C5 were obtained from Meloy Laboratories, Inc., Springfield, Va.
PMN chemotaxis. PMN were obtained from venous blood of a healthy adult donor by a previously described method (9) . PMN random motility and directed migration (chemotaxis) were assessed by using a minor modification of the "leading front" method of Zigmond and Hirsch (8) . Aliquots (0.8 ml) of leukocyte suspensions (containing 2.5 x 106 PMN/ml) were added to the upper compartments of modified Boyden chambers (Nucleopore Corp., Pleasanton, Calif.) Dilutions of treated and untreated sera, or buffer, were placed in the lower compartments. Chambers containing cells and chemoattractants were incubated at 37°C for 35 min in an atmosphere of 5% CO2 and 100% humidity. The filters were then removed, fixed in methanol, stained with hematoxylin, dehydrated in ethanol, and cleared in xylene. The response of PMN either to buffer alone (random motility) or to chemotactic stimuli is reported as the distance that the leading front of cells migrated into the filters (micrometers/35 min).
RESULTS
Effect of 405 nm irradiation on the activity of complement in normal human serum containing uroporphyrin. Irradiation for 30 min of normal human serum containing uroporphyrin (0.6-10 ,tglml) resulted in a marked diminution of total hemolytic complement activity, hemolytic titers of C3 and CS (Fig. 1) , as well as titers of Cl, C4, and C2 (not shown). Changes in complement hemolytic activity were dependent upon the concentration of uroporphyrin in serum. Significant changes were observed at a uroporphyrin concentration of 0.6 pLg/ml. No alteration of hemolytic complement activity was observed in uroporphyrin-containing serum that was kept in the dark, nor in irradiated normal human sera that did not contain uroporphyrin. The diminution of complement activity was associated with the generation of cleavage products of C3 and C5, as evidenced by the appearance of an additional anodal precipitant peak on two-dimensional immunoelectrophoresis when uroporphyrin-containing serum was irradiated. Irradiation of uroporphyrin-containing serum with ultraviolet-B did not result in any alteration of complement hemolytic activity (data not shown). Furthermore, the effect of 405 nm irradiation on complement activity was dependent on the duration of irradiation (data not shown).
Generation of complement (C5)-derived chemotactic activity by irradiation of normal serum containing uroporphyrin. Exposure of human serum containing uroporphyrin (5 ,tg/ml) to 405 nm light for 30 min resulted in the generation of potent chemotactic activity for human PMN (Table I) . When serum was irradiated in the absence of uroporphyrin, or when serum containing uroporphyrin was kept in the dark, no chemotactic activity could be detected. The chemotactic activity resisted heating at 56°C for 30 min and was inhibitable by antisera to human C5 but not by antisera to human C3 (Table I) . Generation of chemotactic activity in normal human serum was dependent upon the concentration of uroporphyrin (Fig. 2) , with 10 ,ug/ml of uroporphyrin generated chemotactic activity of the same magnitude as that generated in zymosanactivated serum. Furthermore, the chemotactic activity generated in serum containing 0.1 ,.tg/ml of uroporphyrin was dependent upon the duration of the irradiation (Fig. 3) . The chemotactic activity was characterized further bu molecular sieve chromatography. 1 ml of irradiated human serum containing uroporphyrin (5.0 ,ug/ml) was applied to a 2.5 x 40-cm calibrated column of Sephadex G-75 (Pharmacia Fine Chemicals, Piscataway, N. J.).
Elution was performed with phosphate (10 mM)-buffered 140 mM NaCl, pH 7.4, at a flow rate of 10 ml/h. 3 ml fractions were collected and assayed for chemotactic activity. As shown in Fig. 4 , a single peak of chemotactic activity was eluted with apparent molecular weight of 15,000. The chemotactic activity in these fractions was heat-stable (56°C for 30 min), and inhibitable by incubation with anti-human C5 but not with anti-human C3 antisera. This elution profile was similar to the elution profile of C5-derived chemotactic activity observed when zymosan-treated serum was chromatographed under identical conditions (8) .
These data indicate that the chemotactic activity generated by irradiation of serum containing uroporphyrin is derived primarily from the fifth component of Eluate Volume (ml) FIGURE 4 Sephadex G75 elution profile of irradiated serum containing uroporphyrin (A) and of zymosan-activated serum (B). There is a single peak ofchemotactic activity in irradiated serum containing uroporphyrin, which is identical to that obtained from zymosan-treated serum. Results are expressed as net chemotaxis.
complement (C5). This was confirmed in experiments using serum from a patient with hereditary deficiency of CS (Table II) . C5-deficient serum containing uroporphyrin did not yield any chemotactic activity after exposure to 405 nm light; upon reconstitution of the C5-deficient serum with purified human C5, chemotactic activity was generated. Participation of the classical pathway of complement activation in the generation of chemotactic activity. To determine which pathway of complement activation is involved in the generation of chemotactic activity, uroporphyrin was added to human serum that had been rendered 2.0 mM with respect to MgCl2, and 20 mM with respect to EGTA, to effectively block activation ofthe classical complement pathway (10) . As shown in Table II , when such serum was irradiated, it failed to yield chemotactic activity. To further demonstrate the participation of the classical pathway, C4-deficient guinea pig serum was used. Irradiation of normal guinea pig serum containing uroporphyrin resulted in the generation of significant chemotactic activity, whereas no chemotactic activity could be detected when C4-deficient guinea pig serum was treated under identical conditions. These results indicate that an intact classical pathway of complement activation is required for the generation of chemotactic activity in irradiated serum containing uroporphyrin.
DISCUSSION
The results of the experiments described in this report indicate that irradiation of normal human serum containing uroporphyrin with light having the action spectrum of porphyrin molecules (405 nm) results in activation of the complement system via the classical (Fig. 1) , Cl, C4, and C2 were dependent upon the concentration of uroporphyrin added to the serum and on the duration of irradiation. That the specific action spectrum ofporphyrins was required for this effect was demonstrated by the lack of any alteration of complement profile in serum containing uroporphyrin that was exposed to ultraviolet-B irradiation. Generation of chemotactic activity for human PMN also was dependent upon the concentration in serum of uroporphyrin and on the duration of irradiation ( Table I, Figs. 2 and 3) . The chemotactic activity resisted heating at 56°C for 30 min and it was inhibited completely by treatment with antisera to human C5 (Table I) ; it could be eluted from Sephadex G-75 column in a single peak with an apparent molecular weight of 15,000 (Fig. 4) . This elution profile was identical to the elution profile of C5-derived chemotactic activity observed after chromatography of serum that had been activated with zymosan. Furthermore, serum from a patient with hereditary deficiency of C5 failed to yield chemotactic activity unless it was reconstituted with purified human C5 (Table II) . These results indicated that the chemotactic activity generated is derived from C5. Evidence that the classical pathway of complement activation is essential for the generation of chemotactic activity in irradiated serum containing uroporphyrin was provided by the experiments summarized in Table II . Neither human serum treated with Mg2+-EGTA (which blocks activation of the classical complement pathway) (10) nor C4-deficient guinea pig serum yielded chemotactic activity. The mechanism by which the classical pathway is activated however, remains to be elucidated. Solar irradiance (400-410 nm range) at sea level with the sun directly overhead is -1,100 gW/cm2 (11) . This is more than five times greater than the output of the light source used in these experiments (200 ,tW/cm2 measured at 15 cm). Taking into account that the total transmission of light in the wavelength range of 400-410 nm through the epidermis of Caucasians is -50% (12) , it is clear that a similar dose of radiation energy as that used in these experiments could be attained in the dermis by exposure to sunlight in the course of regular daily activities. Furthermore, significant chemotactic activity was generated in serum containing 0.1 ,ug/ml of uroporphyrin (Fig. 3) , a concentration similar to that observed in serum from patients with porphyria cutanea tarda (13) . The pathogenesis of cutaneous lesions in the porphyrias is poorly understood. Lysis of endothelial cell following 405 nm irradiation has been observed in animal models (14) and in patients (2); this has been attributed to the action of oxygen-derived free radicals and peroxides (15) . The following observations suggest that complement also may play an important role: deposition of complement components in exposed skin of patients with porphyria cutanea tarda (3) , porphyria variegata (3), and erythropoietic protoporphyria (3, 4) ; loss of hemolytic complement activity in sera from patients with erythropoietic protoporphyria upon 405 nm irradiation (5) and in sera from guinea pigs that had been injected intraperitoneally with porphyrins (6) . Histologically, in patients as well as in animals, there is dermal edema immediately after irradiation, followed by infiltration with PMN and degranulation of mast cells (2, 6, 14) . In this report, we have presented data indicating that complement (C5)-derived chemotactic activity is generated by 405 nm irradiation of serum containing uroporphyrin. These data, taken together with our recent observations that irradiation of sera from patients with erythropoietic protoporphyria results in the generation of chemotactic activity for human PMN (16) , suggest the possibility that complement (C5)-derived peptides play an important role in the pathogenesis of cutaneous lesions in the porphyrias. Such peptides, generated by 405 nm irradiation in the papillary dermis, can increase vascular permeability, resulting in dermal edema, and provoke local accumulation of PMN (17) , resulting in further tissue damage and amplification of the inflammatory process. Thus, complement-mediated inflammation and tissue injury may account, at least in part, for the cutaneous lesions that develop in patients with porphyria.
